Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The endothelial cells that form capillaries in the brain are highly specialized, with tight junctions that minimize paracellular transport and an array of broad-spectrum efflux pumps that make drug delivery to the brain extremely challenging. One of the major limitations in blood-brain barrier research and the development of drugs to treat central nervous system diseases is the lack of appropriate cell lines. Recent reports indicate that the derivation of human brain microvascular endothelial cells (hBMECs) from human induced pluripotent stem cells (iPSCs) may provide a solution to this problem. Here we demonstrate the derivation of hBMECs extended to two new human iPSC lines: BC1 and GFP-labeled BC1. These hBMECs highly express adherens and tight junction proteins VE-cadherin, ZO-1, occludin, and claudin-5. The addition of retinoic acid upregulates VE-cadherin expression, and results in a significant increase in transendothelial electrical resistance to physiological values. The permeabilities of tacrine, rhodamine 123, and Lucifer yellow are similar to values obtained for MDCK cells. The efflux ratio for rhodamine 123 across hBMECs is in the range 2-4 indicating polarization of efflux transporters. Using the rod assay to assess cell organization in small vessels and capillaries, we show that hBMECs resist elongation with decreasing diameter but show progressive axial alignment. The derivation of hBMECs with a blood-brain barrier phenotype from the BC1 cell line highlights that the protocol is robust. The expression of GFP in hBMECs derived from the BC1-GFP cell line provides an important new resource for BBB research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dhBMEC monolayers express a wide range of BBB markers, including tight junction (TJ) proteins (Fig. 1b), transporters, and efflux pumps, and typically attain transendothelial electrical resistance (TEER) > 1500 Ω cm2 [27, 28, 31, 34–37].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“IMR90-4 was induced from fetal fibroblasts using lentiviral vectors; DF6-9-9T and DF19-9-11T were both induced from foreskin fibroblasts using the oriP/EBNA-1 episomal vector [15, 16].”
MethodStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917
Claudins and the Modulation of Tight Junction Permeability
Günzel, D., & Yu, A. S. L. (2013) · Physiological Reviews · doi:10.1152/physrev.00019.2012 · Cited by 1,456 · cited 1×
“Some claudins have been reported to show nuclear localization [35].”
BackgroundMethods in molecular medicine.
Craig, R. K. (1987) · BMJ · doi:10.1136/bmj.295.6599.646 · Cited by 1,057
The role of adherens junctions and VE-cadherin in the control of vascular permeability
Dejana, E., Orsenigo, F., & Lampugnani, M. G. (2008) · Journal of Cell Science · doi:10.1242/jcs.017897 · Cited by 986 · cited 1×
“Vascular endothelial cadherin (VE-cad) is an adherens junction protein specific to endothelial cells [37].”
BackgroundMDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
Morita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 869
Research works printed but not linked: 1
- Zou C, Chou BK, Dowey SN, Tsang K, Huang X, Liu CF, et al Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines. Stem Cells Dev. 2012; 21(12): 2298– 311. Epub 2012/01/10. 10.1089/scd.2011.0688 22225458 PMC3411364 · DOI
Cited by
Items 101–129 of 129
Nguyen, E. H., Dombroe, M. J., Fisk, D. L., Daly, W. T., Sorenson, C. M., Murphy, W. L., & Sheibani, N. (2019) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0025 · Cited by 8
Neuhaus, W. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.217326 · Cited by 7
“In this context, Katt et al. (2016) already increased the amount of BCECs after hiPSC-differentiation to > 90%.”
BackgroundResultForeman, K. L., Shusta, E. V., & Palecek, S. P. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3287-1_10 · Cited by 6
Pervaiz, I., & Al-Ahmad, A. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2289-6_3 · Cited by 5
Blood-brain-barrier modeling with tissue chips for research applications in space and on Earth
Yau, A., Jogdand, A. H., & Chen, Y. (2023) · Frontiers in Space Technologies · doi:10.3389/frspt.2023.1176943 · Cited by 9
“The use of iPSCs for studying the blood-brain barrier (BBB) in vitro offers several advantages and has become an important tool in BBB research (Katt et al., 2016; Pong et al., 2020; Workman and Svendsen, 2020; Lu et al., 2021).”
MethodIn vitro human brain barrier models for studying thyroid hormone transport
Heikamp, K., Hamers, T., & Hessel, E. V. S. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2540446 · Cited by 3
Identification of Variable Lymphocyte Receptors That Target the Human Blood–Brain Barrier
Katt, M. E., Waters, E. A., Gastfriend, B. D., Herrin, B. R., Cooper, M. D., & Shusta, E. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091179 · Cited by 3
“hiPSC-derived BMEC-like cells were cultured and differentiated from IMR90-4 hiPSC(WiCell) [48], as previously described [24,26].”
InfluentialSelf-citationLin, Y.-Y., Esswein, P. J., Ramirez, L. P., Warren, E. C., Nicenboim, J., & Gerecht, S. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01712-9 · Cited by 6
“The permeability assay was performed on day four, after TEER measurement, following an established protocol 96,103 .”
Self-citationHydrodynamic Focusing-Enabled Blood Vessel Fabrication for in Vitro Modeling of Neural Surrogates
DiVito, K. A., Luo, J., Rogers, K. E., Sundaram, S., Roberts, S., Dahal, B., van Hoek, M. L., Kehn‐Hall, K., Delehanty, J. B., & Adams, A. A. (2021) · Journal of Medical and Biological Engineering · doi:10.1007/s40846-021-00629-9 · Cited by 5
Human In Vitro Blood-Brain Barrier Models Derived from Stem Cells
Foreman, K. L., Palecek, S. P., & Shusta, E. V. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_9 · Cited by 2
Effects of novel mRNA-VEGF@USPIO nanoparticles on human brain microvascular endothelial cell injury
Zhao, J., & Qian, Z. (2023) · General Physiology and Biophysics · doi:10.4149/gpb_2023032 · Cited by 2
Impaired retinoic acid signaling in cerebral cavernous malformations
Grdseloff, N., Boulday, G., Rödel, C. J., Otten, C., Vannier, D., Cardoso, C., Faurobert, E., Dogra, D., Tournier‐Lasserve, E., & Abdelilah‐Seyfried, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-31905-0 · Cited by 3
Three-dimensional induced pluripotent stem-cell models of human brain angiogenesisPreprint
Searson, P. C., Linville, R. M., Arevalo, D., Maressa, J. C., & Zhao, N. (2019) · Research Square · doi:10.21203/rs.2.18502/v1 · Cited by 2
“Methods Cell culture Brain microvascular endothelial cells (BMECs) were differentiated from hiPSCs similar to published protocols [15, 27].”
MethodSelf-citationKönig, L., Khin, M., Puris, E., Petralla, S., Gericke, B., & Fricker, G. (2026) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2026.115111 · Cited by 1
In vitro blood–brain barrier model derived from human iPS cells and its applications
Zhang, H., Yamaguchi, T., & Kawabata, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822231-7.00003-5 · Cited by 2
The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation
Kala, S., Strutz, A. G., & Katt, M. E. (2025) · Neurology International · doi:10.3390/neurolint17010006 · Cited by 2
“…differentiations that produce cells with marginal endothelial phenotypes but display strong barrier properties and tight junction expression [25,149–151], and endothelial cells that have been differentiated through endothelial progenitor cells (EPCs), with the addition of small molecules to…”
Self-citationBonney, S. K., Mishra, S., Pleasure, S. J., & Siegenthaler, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814405-3.00043-6
Linville, R. M., Nerenberg, R. F., Grifno, G. N., Arevalo, D., Guo, Z., & Searson, P. C. (2022) · Figshare · doi:10.6084/m9.figshare.20208314
Self-citationLinville, R. M., Maressa, J. C., Guo, Z., Chung, T. D., Farrell, A. M., Jha, R., & Searson, P. C. (2024) · Figshare · doi:10.6084/m9.figshare.26635392
Self-citationAdditional file 1 of Commentary on human pluripotent stem cell-based blood–brain barrier models
Lippmann, E. S., Azarin, S. M., Palecek, S. P., & Shusta, E. V. (2020) · Figshare · doi:10.6084/m9.figshare.13115217
Yamashita, M., Aoki, H., Hashita, T., Iwao, T., & Matsunaga, T. (2020) · Figshare · doi:10.6084/m9.figshare.12375572
Baringer, S. L., Palsa, K., Spiegelman, V. S., Simpson, I. A., & Connor, J. R. (2024) · Figshare · doi:10.6084/m9.figshare.26594333
Linville, R. M., Maressa, J. C., Guo, Z., Chung, T. D., Farrell, A. M., Jha, R., & Searson, P. C. (2024) · Figshare · doi:10.6084/m9.figshare.26635395
Self-citationChung, T. D., Liang, L. R., Wang, L., Kim, E. G., Gupta, S., Pandey, I., & Searson, P. C. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00773-x
Self-citationCox, B., Karra-Bhardwaj, N., Chothe, P. P., Class, R., Kang, S., Meyer, A. H., Mezler, M., McAuliffe, J., Petrungaro, C., Ramírez-Moya, J., et al. (2026) · ALTEX · doi:10.14573/altex.2411221
Jain, S., Kriti, K., & Acharya, R. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815523126010010
Manko, T., Luz, I., Zorsky, M., Feinstein, V., David, S. B., Beit‐Yannai, E., Vatine, G. D., & Cooks, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.06.749705
Larsen, B., Callahan, C. J., Rayanki, A., McClain, A. K., Wu, W., Faulkner, S., & Zoldan, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10899210/v1
Hwang, R. W., Li, Y. B., Marcotte, R., Costain, W., & Jezierski, A. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103116
Metadata
- Authors
- Katt, M. E., Xu, Z. S., Gerecht, S., & Searson, P. C.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Searson, Peter C.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-04-12
- Volume
- 11
- Issue
- 4
- Pages
- e0152105
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4829259
- OpenAlex
- W2341259444
- Cited by
- 129
- References
- 48
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 8 · 2023: 14 · 2022: 12 · 2021: 16 · 2020: 18 · 2019: 20 · 2018: 11 · 2017: 12 · 2016: 5
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (R01CA170629)
- Defense Threat Reduction Agency (US) (HDTRA1-15-1-0046)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- human brain microvascular endothelial cells, blood-brain barrier, induced pluripotent stem cells, retinoic acid, tight junction proteins, VE-cadherin, claudin-5, transendothelial electrical resistance, efflux pumps, rhodamine 123 efflux, cell polarization, cell alignment, GFP-labeled cells
- MeSH terms
- Cadherin 5, Biological Transport, Blood-Brain Barrier, Brain, Capillaries, Cell Line, Humans, Phenotype, Antigens, CD, Cadherins, Up-Regulation, Tight Junctions, Rhodamine 123, Endothelial Cells, Induced Pluripotent Stem Cells, Claudin-5, Occludin, Zonula Occludens-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.